Pazopanib Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

48 API Suppliers, 14 USDMF, 1 JDMF, 8 EU WC, 5 KDMF, 9 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

INTERMEDIATES

45 Intermediate Suppliers

45 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

75 FDF Dossiers, 8 FDA Orange Book, 28 Europe, 3 Canada, 12 Australia, 5 South Africa, 19 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 200MG BASE, TABLET;ORAL - EQ 400MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 5 DKSH, 1 Boai NKY Pharmaceuticals Ltd, 3 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 2 Actylis, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 10 BASF, 1 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 10 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 2 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 12 Seppic, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Coating Systems & Additives, 30 Fillers, Diluents & Binders, 17 Solubilizers, 17 Controlled & Modified Release, 16 Thickeners and Stabilizers, 15 Disintegrants & Superdisintegrants, 13 Granulation, 13 Direct Compression, 10 Film Formers & Plasticizers, 10 Lubricants & Glidants, 9 Parenteral, 8 Co-Processed Excipients, 6 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 5 Emulsifying Agents, 5 Topical, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 API Stability Enhancers, 4 Taste Masking, 4 Chewable & Orodispersible Aids

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 15 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 10 Annual Reports

MARKET PLACE

2 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP

3 USP

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 22465 / DOSAGE - TABLET;ORAL - EQ 200MG BASE

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PAZOPANIB HYDROCHLORIDE(UNII: 33Y9ANM545) (PAZOPANIB - UNII:7RN5DR86CK)	PAZOPANIB	200mg

Inactive Ingredients

Ingredient Name	GlaxoSmithKline LLC	SUN PHARMACEUTICAL INDUSTRIES, INC.
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERROSOFERRIC OXIDE(XM0M87F357)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
HYPROMELLOSES(3NXW29V3WO)
MAGNESIUM STEARATE(70097M6I30)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
POLYSORBATE 80(6OZP39ZG8H)
POVIDONE, UNSPECIFIED(FZ989GH94E)
POVIDONES(FZ989GH94E)
SODIUM STARCH GLYCOLATE TYPE A POTATO(5856J3G2A2)
TITANIUM DIOXIDE(15FIX9V2JP)

Setid F5b7b3a4 C3a4 4722 8ca5 8f6a5c622553 Applno 22465 Form Tablet Oral Dosage Eq 200mg Base - Drug Product Composition: Pazopanib Hydrochloride